Orforglipron trial beats oral semaglutide on weight loss and blood sugar
A once-daily pill delivers stronger trial results than leading oral semaglutide, with logistics and cost advantages over injections.
By Abdullah Al-Otaibi·· 3 min
Loading the Newsroom
Curating from trusted global sources…